@prefix this: . @prefix sub: . @prefix np: . @prefix pav: . @prefix xsd: . @prefix orcid: . @prefix rdfs: . @prefix biolink: . @prefix prov: . @prefix mesh: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { mesh:D003094 a biolink:ChemicalEntity; rdfs:label "collagen"; biolink:category biolink:ChemicalEntity . a biolink:ChemicalEntity; rdfs:label "methylprednisolone"; biolink:category biolink:ChemicalEntity . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "epicondylitis"; biolink:category biolink:DiseaseOrPhenotypicFeature . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "bursitis"; biolink:category biolink:DiseaseOrPhenotypicFeature . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "tenosynovitis"; biolink:category biolink:DiseaseOrPhenotypicFeature . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "allergic"; biolink:category biolink:DiseaseOrPhenotypicFeature . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "gouty arthritis"; biolink:category biolink:DiseaseOrPhenotypicFeature . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "rheumatoid arthritis"; biolink:category biolink:DiseaseOrPhenotypicFeature . } sub:provenance { sub:assertion prov:generatedAtTime "2022-10-11T10:06:47.108142"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-3668-2627; prov:wasQuotedFrom " Oral and intramuscular methylprednisolone are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, allergic and ophthalmic, respiratory, hematologic, neoplastic, edematous, gastrointestinal, nervous system, and other disorders. Intra-articular and soft tissue injections are. indicated for short term treatment of acute gouty arthritis, acute and subactute bursitis, acute nonspecific tenosynovitis, epicondylitis, and rheumatoid arthritis." . biolink: pav:version "2.3.0" . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB"; npx:hasSignature "Q47bC0rDUCetddiC+Sg4f4M/2Y+vMzgfTLlbHqK7F5pn3EXGoK77U3FCtBL1TU/q1MAaqHdLzJcEjvTrzCQSRqxhXFNAHtXmAFIQodwckBQkzkNbDtWLxYYHO2kClZARWsRrHZjsgRzYucBrsBIIGxN11HORw7Qf1tXR8mGEgV626lc0FGv8RXU0GlQP28oZVg6g2Ee/DfE7LudjO94bVy3Hw9H7+xX00POw+5YtPCbmIIuPqGtBD5HL1kDaGPoUpI94eOZlvrxpzoJcBn/11+XWEUWPzN6xqidL0CFqd9XpsD88C1V/w3DFHJ8P9RiKincaM8illf3VDcKUKK7UGg=="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2022-10-11T10:06:47.108142"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-3668-2627 . }